Central Trust CO Cv Sciences, Inc. Transaction History

Central Trust CO

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Jan 08, 2019	SELL	$3.55 - $6.4 $1,775 - $3,200	-500 Closed	0 $0
Q3 2018 Oct 04, 2018	SELL	$1.6 - $7.13 $640 - $2,852	-400 Reduced 44.44%	500 $0
Q2 2018 Jul 09, 2018	BUY	$0.41 - $2.41 $369 - $2,169	900 New	900 $0

5.1K

Ticker CVSI
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 147,794,000
Market Cap $7.39M
Description
CV Sciences, Inc. operates as a life science company in North America. It operates in two segments, Consumer Products and Specialty Pharmaceutical. The Consumer Products segment develops, manufactures, and markets plant-based dietary supplements and hemp-based cannabidiol (CBD) products under the PlusCBD, ProCBD, HappyLane, CV Acute, CV Defense,...

Get notified when there are updates to the investment portfolio of Central Trust CO, based on Form 13F filings with the SEC.

Stay updated on Central Trust CO with notifications on news.